Literature DB >> 15004176

Concomitant helper response rescues otherwise low avidity CD8+ memory CTLs to become efficient effectors in vivo.

Udayasankar Kumaraguru1, Susmit Suvas, Partha S Biswas, Ahmet Kursat Azkur, Barry T Rouse.   

Abstract

This report seeks a means of maximizing memory CD8 T cell responses to peptide immunization. Delivery of the CD8 peptide epitope by stress protein, heat shock protein (hsp)70, results in excellent immunogenicity at the acute phase but memory responses were poor both in terms of the number of responding cells as well as their functional avidity. We demonstrate for the first time that hsp70 can also be used as a vehicle to achieve CD4 T cell responses to loaded peptide epitopes and that coimmunization with hsp70 loaded with both CD8 and CD4 peptide epitopes may increase memory up to 3-fold. Furthermore, CD8+ T cell memory responses were of higher avidity measured both by in vitro cytotoxicity assays and a new methodology that measures the avidity of CTL activity in vivo in mice. Our results emphasize that peptide immunization remains a viable approach to induce long-term CD8+ T cell function, providing steps are taken to assure appropriate stimulation of Th cell responses.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15004176     DOI: 10.4049/jimmunol.172.6.3719

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  8 in total

1.  Role of PD-1 and its ligand, B7-H1, in early fate decisions of CD8 T cells.

Authors:  Monica V Goldberg; Charles H Maris; Edward L Hipkiss; Andrew S Flies; Lijie Zhen; Rubin M Tuder; Joseph F Grosso; Timothy J Harris; Derese Getnet; Katharine A Whartenby; Dirk G Brockstedt; Thomas W Dubensky; Lieping Chen; Drew M Pardoll; Charles G Drake
Journal:  Blood       Date:  2007-03-28       Impact factor: 22.113

2.  Effective depletion of regulatory T cells allows the recruitment of mesothelin-specific CD8 T cells to the antitumor immune response against a mesothelin-expressing mouse pancreatic adenocarcinoma.

Authors:  Ihid C Leao; Priya Ganesan; Todd D Armstrong; Elizabeth M Jaffee
Journal:  Clin Transl Sci       Date:  2008-12       Impact factor: 4.689

3.  An intranasal heat shock protein based vaccination strategy confers protection against mucosal challenge with herpes simplex virus.

Authors:  Christopher D Pack; Malgorzata Gierynska; Barry T Rouse
Journal:  Hum Vaccin       Date:  2008-09-28

4.  Natural killer cells as novel helpers in anti-herpes simplex virus immune response.

Authors:  Subhadra Nandakumar; Stacie N Woolard; Dorothy Yuan; Barry T Rouse; Uday Kumaraguru
Journal:  J Virol       Date:  2008-08-20       Impact factor: 5.103

5.  Tc17 CD8 T cells: functional plasticity and subset diversity.

Authors:  Hung-Rong Yen; Timothy J Harris; Satoshi Wada; Joseph F Grosso; Derese Getnet; Monica V Goldberg; Kai-Li Liang; Tullia C Bruno; Kristin J Pyle; Siaw-Li Chan; Robert A Anders; Cornelia L Trimble; Adam J Adler; Tzou-Yien Lin; Drew M Pardoll; Ching-Tai Huang; Charles G Drake
Journal:  J Immunol       Date:  2009-11-16       Impact factor: 5.422

Review 6.  Immunotherapy for human cancer using heat shock protein-peptide complexes.

Authors:  Pramod K Srivastava
Journal:  Curr Oncol Rep       Date:  2005-03       Impact factor: 5.945

7.  Hexokinase II may be dispensable for CD4 T cell responses against a virus infection.

Authors:  Siva Karthik Varanasi; Ujjaldeep Jaggi; Nissim Hay; Barry T Rouse
Journal:  PLoS One       Date:  2018-01-19       Impact factor: 3.240

8.  Generation in vivo of peptide-specific cytotoxic T cells and presence of regulatory T cells during vaccination with hTERT (class I and II) peptide-pulsed DCs.

Authors:  Mark M Aloysius; Alastair J Mc Kechnie; Richard A Robins; Chandan Verma; Jennifer M Eremin; Farzin Farzaneh; Nagy A Habib; Joti Bhalla; Nicola R Hardwick; Sukchai Satthaporn; Thiagarajan Sreenivasan; Mohammed El-Sheemy; Oleg Eremin
Journal:  J Transl Med       Date:  2009-03-19       Impact factor: 5.531

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.